A - Human Necessities – 61 – M
Patent
A - Human Necessities
61
M
A61M 25/00 (2006.01) A61L 27/28 (2006.01) A61L 27/54 (2006.01) A61M 31/00 (2006.01)
Patent
CA 2466636
A long term oxygen therapy system having an oxygen supply directly linked with a patient's lung or lungs may be utilized to more efficiently treat hypoxia caused by chronic obstructive pulmonary disease such as emphysema and chronic bronchitis. The system includes an oxygen source, one or more valves and fluid carrying conduits. The fluid carrying conduits link the oxygen source to diseased sites within the patient's lungs. A collateral ventilation bypass trap system directly linked with a patient's lung or lungs may be utilized to increase the expiratory flow from the diseased lung ar lungs, thereby treating another aspect of chronic obstructive pulmonary disease. The system includes a trap, a filter/one-way valve and an air carrying conduit. In order for the system to be effective, an air-tight seal between the parietal and visceral pleurae is required. Chemical pleurodesis is utilized for creating the seal.
Russell Scott M.
Tanaka Don A.
Cordis Corporation
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
Portaero Inc.
LandOfFree
Localized pleurodesis chemical delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Localized pleurodesis chemical delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Localized pleurodesis chemical delivery will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1676377